Table 4. Bedaquiline-containing treatments according to the outcomes.

DR treatment used	Alive n = 17	Died n = 15
4 Am, 6 Bdq Hhd, PAS, Lzd, Cfz, Z/14 Lzd, PAS, Cfz, Z	3(17,6)	8(53,3)
4 Am, 6Bdq Hhd, Lfx, Lzd, Cfz, Z/14 Lfx, Lzd, Cfz, Z	1(5,9)	3(20,0)
6 Lfx, Bdq, Hhd, PAS, Lzd, Cfz, Z/14 Lfx, Lzd, PAS, Cfz, Z	0(0,0)	2(13,3)
4 Am 6 Bdq, PAS, Lzd, Cfz, Z/14 Pas, Lzd, Cfz, Z	6(35,3)	1(6,7)
6 Km, Bdq, Hhd, Pas, Lzd, Cfz, Z/14 Lzd, PAS, Cfz, Z	0(0,0)	1(6,7)
4 Am, 6 Bdq, PAS, Lzd, Cfz, Z/14 Lzd, PAS, Cfz, Z	2(11,8)	0(0,0)
6Am, Bdq, Pto, PAS, Lzd, Cs, Z/14 PAS, Lzd, Cs, Z	2(11,8)	0(0,0)
6 Km, Bdq, Hhd, PAS, Lzd, Cfz, Z/14 Lzd, PAS, Cfz, Z	2(11,8)	0(0,0)
6 Mpm-clv, Bdq, PAS, Lzd, Cfz, Z/6 Bdq, PAS, Lzd, Cfz, Z/8 PAS, Lzd, Cfz, Z	1(5,9)	0(0,0)

Am: Amikacin, Km: Kanamycin, Bdq: Bedaquiline, Hhd: High-dose isoniazid, PAS: Para-amino salicylic acid, Lzd: Linezolid, Cfz: Clofazimine, Z: Pyrazinamide, Lfx: Levofloxacin, Pto: Prothionamide, Mpm-clv: Meropenem–clavulanic acid, Cs: Cycloserine